KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Starbucks (SBUX) Current Deferred Revenue (2016 - 2025)

Starbucks (SBUX) has disclosed Current Deferred Revenue for 17 consecutive years, with $2.1 billion as the latest value for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue fell 4.13% to $2.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.1 billion, a 4.13% decrease, with the full-year FY2025 number at $1.8 billion, up 7.09% from a year prior.
  • Current Deferred Revenue was $2.1 billion for Q4 2025 at Starbucks, up from $1.8 billion in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $2.2 billion in Q4 2024 to a low of $1.4 billion in Q2 2021.
  • A 5-year average of $1.8 billion and a median of $1.7 billion in 2024 define the central range for Current Deferred Revenue.
  • Peak YoY movement for Current Deferred Revenue: increased 18.25% in 2024, then fell 4.13% in 2025.
  • Starbucks' Current Deferred Revenue stood at $1.4 billion in 2021, then grew by 3.76% to $1.5 billion in 2022, then surged by 44.36% to $2.2 billion in 2023, then increased by 2.0% to $2.2 billion in 2024, then decreased by 4.13% to $2.1 billion in 2025.
  • Per Business Quant, the three most recent readings for SBUX's Current Deferred Revenue are $2.1 billion (Q4 2025), $1.8 billion (Q3 2025), and $1.9 billion (Q2 2025).